Compounds > quinazolines
Page last updated: 2024-08-21

quinazolines and Osteolysis

quinazolines has been researched along with Osteolysis in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baron, F; Beguin, Y; Binsfeld, M; Caers, J; Carmeliet, G; Cohen-Solal, M; Dubois, S; Heusschen, R; Léonard, A; Mahli, N; Marty, C; Menu, E; Moermans, K; Muller, J; Plougonven, E1
Bai, L; Evans, CP; Gao, AC; Kung, HJ; Yang, JC; Yap, S1
Fujimoto-Ohuchi, K; Furugaki, K; Iwai, T; Kondoh, K; Mori, K; Moriya, Y; Yanagisawa, M; Yorozu, K1

Other Studies

3 other study(ies) available for quinazolines and Osteolysis

ArticleYear
SRC kinase inhibition with saracatinib limits the development of osteolytic bone disease in multiple myeloma.
    Oncotarget, 2016, May-24, Volume: 7, Issue:21

    Topics: Administration, Oral; Animals; Benzodioxoles; Bone and Bones; Cell Differentiation; Cell Line, Tumor; Disease Models, Animal; Female; Humans; Male; Mice; Mice, Inbred C57BL; Multiple Myeloma; Osteoblasts; Osteoclasts; Osteolysis; Protein Kinase Inhibitors; Proto-Oncogene Mas; Proto-Oncogenes; Quinazolines; src-Family Kinases

2016
Effect of the specific Src family kinase inhibitor saracatinib on osteolytic lesions using the PC-3 bone model.
    Molecular cancer therapeutics, 2010, Volume: 9, Issue:6

    Topics: Animals; Antineoplastic Agents; Benzodioxoles; Bone and Bones; Cell Differentiation; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; Humans; Male; Mice; Neoplasm Invasiveness; Osteoclasts; Osteogenesis; Osteolysis; Protein Kinase Inhibitors; Quinazolines; Radiography; RANK Ligand; Signal Transduction; src-Family Kinases; Xenograft Model Antitumor Assays

2010
Erlotinib inhibits osteolytic bone invasion of human non-small-cell lung cancer cell line NCI-H292.
    Clinical & experimental metastasis, 2011, Volume: 28, Issue:7

    Topics: Animals; Bone Neoplasms; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Disease Models, Animal; ErbB Receptors; Erlotinib Hydrochloride; Humans; Male; Mice; Neoplasm Invasiveness; Osteoblasts; Osteolysis; Protein Kinase Inhibitors; Quinazolines

2011